For example, more than 30% of patients using GLP-1 therapies for obesity discontinue within the first month and nearly 60% stop within three months, underscoring the importance of identifying and prioritizing potential high-risk periods for proactive monitoring and targeted intervention, if needed
Biochemical assessments of peripheral blood from AD patients demonstrated significantly elevated levels of the mitochondrial fission factor Fis1, with postmortem brain specimens further revealing upregulated Drp1 expression in AD cases (Pakpian et al., 2020)
It could be given orally orillegally, a slide readas a subcutaneous injection
The medication suppresses parts of the immune system and may increase the risk of infections, blood clots, cardiovascular events, and certain cancers, particularly if taken without proper medical oversight